BCIQ Profiles

Company Profile ReportTarget Profile Report

STAT3-based gene signature to predict response to glioblastoma targeted therapy


TECHNOLOGY: Gene profiling

A STAT3-based gene expression signature could identify glioblastoma multiforme (GBM) patients that will respond to STAT3 inhibitors as monotherapies or in

Read the full 252 word article

How to gain access

Continue reading with a
two-week free trial.